12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, health care stocks saw significant movements. Geron (GERN) led the gainers with a 90.8% increase, while Kineta (KA) experienced the largest drop among the losers, declining by 8.3%. Notably, Akebia Therapeutics (AKBA) rose by 8.02% following its Q4 earnings report.
March 14, 2024 | 9:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kineta stock declined by 8.3% to $0.56, with a market value of their outstanding shares at $5.8 million.
The decline in KA's stock price suggests negative sentiment or disappointing news affecting investor confidence.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Akebia Therapeutics stock rose 8.02% to $1.48 after its Q4 earnings report, with a market cap of $278.7 million.
The positive reaction to AKBA's Q4 earnings report suggests the results were favorable, leading to increased investor interest.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Geron stock surged 90.8% in after-market trading, reaching $3.34 with a market cap of $1.8 billion.
The significant surge in GERN's stock price indicates strong investor confidence, potentially due to positive developments or expectations.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100